Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
May 1, 1994
Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation
R Dolhofer-Bliesener, B Lechner, K D Gerbitz
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
April 1, 1996
Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes
R Dolhofer-Bliesener, B Lechner, K D Gerbitz
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
January 1, 1990
Differential kinetics of glucose metabolism in porcine retinal and aortic endothelial cells
B Olgemöller, E D Schleicher, K D Gerbitz
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
April 1, 1977
Human alkaline phosphatases. I. Purification and some structural properties of the enzyme from human liver
K D Gerbitz, H J Kolb, O H Wieland
Diabetologia
|
February 1, 1992
Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells
B Olgemöller, S Schwaabe, K D Gerbitz, et al.
Clinical Chemistry
|
April 1, 1993
Specific glycation of albumin depends on its half-life
E D Schleicher, B Olgemöller, E Wiedenmann, et al.
Biochimica Et Biophysica Acta
|
April 9, 1990
Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells
B Olgemöller, S Schwaabe, E D Schleicher, et al.
The American Journal of Physiology
|
October 1, 1994
Heparin induces endothelial extracellular matrix alterations and barrier dysfunction
H J Guretzki, E Schleicher, K D Gerbitz, et al.
Atherosclerosis
|
May 1, 1994
Atherogenic levels of low density lipoprotein alter the permeability and composition of the endothelial barrier
H J Guretzki, K D Gerbitz, B Olgemöller, et al.
Diabetes
|
August 1, 1993
Upregulation of myo-inositol transport compensates for competitive inhibition by glucose. An explanation for the inositol paradox?
B Olgemöller, S Schwaabe, E D Schleicher, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
May 1, 1994
Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation
R Dolhofer-Bliesener, B Lechner, K D Gerbitz
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
April 1, 1996
Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes
R Dolhofer-Bliesener, B Lechner, K D Gerbitz
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
January 1, 1990
Differential kinetics of glucose metabolism in porcine retinal and aortic endothelial cells
B Olgemöller, E D Schleicher, K D Gerbitz
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
April 1, 1977
Human alkaline phosphatases. I. Purification and some structural properties of the enzyme from human liver
K D Gerbitz, H J Kolb, O H Wieland
Diabetologia
|
February 1, 1992
Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells
B Olgemöller, S Schwaabe, K D Gerbitz, et al.
Clinical Chemistry
|
April 1, 1993
Specific glycation of albumin depends on its half-life
E D Schleicher, B Olgemöller, E Wiedenmann, et al.
Biochimica Et Biophysica Acta
|
April 9, 1990
Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells
B Olgemöller, S Schwaabe, E D Schleicher, et al.
The American Journal of Physiology
|
October 1, 1994
Heparin induces endothelial extracellular matrix alterations and barrier dysfunction
H J Guretzki, E Schleicher, K D Gerbitz, et al.
Atherosclerosis
|
May 1, 1994
Atherogenic levels of low density lipoprotein alter the permeability and composition of the endothelial barrier
H J Guretzki, K D Gerbitz, B Olgemöller, et al.
Diabetes
|
August 1, 1993
Upregulation of myo-inositol transport compensates for competitive inhibition by glucose. An explanation for the inositol paradox?
B Olgemöller, S Schwaabe, E D Schleicher, et al.
Page
of 7